BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 26826926)

  • 21. Highly Efficient Genome Editing via CRISPR/Cas9 to Create Clock Gene Knockout Cells.
    Korge S; Grudziecki A; Kramer A
    J Biol Rhythms; 2015 Oct; 30(5):389-95. PubMed ID: 26243628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of CD34 Fluorescent Reporter Human Induced Pluripotent Stem Cells for Monitoring Hematopoietic Differentiation.
    Husa AM; Strobl MR; Strajeriu A; Wieser M; Strehl S; Fortschegger K
    Stem Cells Dev; 2018 Oct; 27(19):1376-1384. PubMed ID: 30009677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cloning-free CRISPR/Cas system facilitates functional cassette knock-in in mice.
    Aida T; Chiyo K; Usami T; Ishikubo H; Imahashi R; Wada Y; Tanaka KF; Sakuma T; Yamamoto T; Tanaka K
    Genome Biol; 2015 Apr; 16(1):87. PubMed ID: 25924609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells.
    Liao HK; Gu Y; Diaz A; Marlett J; Takahashi Y; Li M; Suzuki K; Xu R; Hishida T; Chang CJ; Esteban CR; Young J; Izpisua Belmonte JC
    Nat Commun; 2015 Mar; 6():6413. PubMed ID: 25752527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The CRISPR/Cas system can be used as nuclease for in planta gene targeting and as paired nickases for directed mutagenesis in Arabidopsis resulting in heritable progeny.
    Schiml S; Fauser F; Puchta H
    Plant J; 2014 Dec; 80(6):1139-50. PubMed ID: 25327456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of knockout mice by DNA microinjection of various CRISPR/Cas9 vectors into freeze-thawed fertilized oocytes.
    Nakagawa Y; Sakuma T; Sakamoto T; Ohmuraya M; Nakagata N; Yamamoto T
    BMC Biotechnol; 2015 May; 15():33. PubMed ID: 25997509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highly efficient CRISPR/Cas9-mediated transgene knockin at the H11 locus in pigs.
    Ruan J; Li H; Xu K; Wu T; Wei J; Zhou R; Liu Z; Mu Y; Yang S; Ouyang H; Chen-Tsai RY; Li K
    Sci Rep; 2015 Sep; 5():14253. PubMed ID: 26381350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of α-1,3-Galactosyltransferase-Deficient Porcine Embryonic Fibroblasts by CRISPR/Cas9-Mediated Knock-in of a Small Mutated Sequence and a Targeted Toxin-Based Selection System.
    Sato M; Kagoshima A; Saitoh I; Inada E; Miyoshi K; Ohtsuka M; Nakamura S; Sakurai T; Watanabe S
    Reprod Domest Anim; 2015 Oct; 50(5):872-80. PubMed ID: 26138589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Cas9 Variant for Efficient Generation of Indel-Free Knockin or Gene-Corrected Human Pluripotent Stem Cells.
    Howden SE; McColl B; Glaser A; Vadolas J; Petrou S; Little MH; Elefanty AG; Stanley EG
    Stem Cell Reports; 2016 Sep; 7(3):508-517. PubMed ID: 27499201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TALEN/CRISPR-mediated eGFP knock-in add-on at the OCT4 locus does not impact differentiation of human embryonic stem cells towards endoderm.
    Krentz NA; Nian C; Lynn FC
    PLoS One; 2014; 9(12):e114275. PubMed ID: 25474420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous Reprogramming and Gene Correction of Patient Fibroblasts.
    Howden SE; Maufort JP; Duffin BM; Elefanty AG; Stanley EG; Thomson JA
    Stem Cell Reports; 2015 Dec; 5(6):1109-1118. PubMed ID: 26584543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of an OCT4 reporter human induced pluripotent stem cell line using CRISPR/SpCas9.
    Balboa D; Weltner J; Novik Y; Eurola S; Wartiovaara K; Otonkoski T
    Stem Cell Res; 2017 Aug; 23():105-108. PubMed ID: 28925359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of a heterozygous knockout human embryonic stem cell line for the OCIAD1 locus using CRISPR/CAS9 mediated targeting: BJNhem20-OCIAD1-CRISPR-20.
    Shetty DK; Inamdar MS
    Stem Cell Res; 2016 Mar; 16(2):207-9. PubMed ID: 27345969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR/Cas9-mediated reporter knock-in in mouse haploid embryonic stem cells.
    Kimura Y; Oda M; Nakatani T; Sekita Y; Monfort A; Wutz A; Mochizuki H; Nakano T
    Sci Rep; 2015 Jun; 5():10710. PubMed ID: 26039937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Large genomic fragment deletions and insertions in mouse using CRISPR/Cas9.
    Zhang L; Jia R; Palange NJ; Satheka AC; Togo J; An Y; Humphrey M; Ban L; Ji Y; Jin H; Feng X; Zheng Y
    PLoS One; 2015; 10(3):e0120396. PubMed ID: 25803037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knock-in fibroblasts and transgenic blastocysts for expression of human FGF2 in the bovine β-casein gene locus using CRISPR/Cas9 nuclease-mediated homologous recombination.
    Jeong YH; Kim YJ; Kim EY; Kim SE; Kim J; Park MJ; Lee HG; Park SP; Kang MJ
    Zygote; 2016 Jun; 24(3):442-56. PubMed ID: 26197710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of a novel HEK293 luciferase reporter cell line by CRISPR/Cas9-mediated site-specific integration in the genome to explore the transcriptional regulation of the PGRN gene.
    Li Y; Li S; Li Y; Xia H; Mao Q
    Bioengineered; 2019 Dec; 10(1):98-107. PubMed ID: 31023186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of CRISPR/Cas9 editing and digital droplet PCR in human iPSCs to generate novel knock-in reporter lines to visualize dopaminergic neurons.
    Überbacher C; Obergasteiger J; Volta M; Venezia S; Müller S; Pesce I; Pizzi S; Lamonaca G; Picard A; Cattelan G; Malpeli G; Zoli M; Beccano-Kelly D; Flynn R; Wade-Martins R; Pramstaller PP; Hicks AA; Cowley SA; Corti C
    Stem Cell Res; 2019 Dec; 41():101656. PubMed ID: 31733438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One-step generation of triple knockout CHO cell lines using CRISPR/Cas9 and fluorescent enrichment.
    Grav LM; Lee JS; Gerling S; Kallehauge TB; Hansen AH; Kol S; Lee GM; Pedersen LE; Kildegaard HF
    Biotechnol J; 2015 Sep; 10(9):1446-56. PubMed ID: 25864574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
    Yumlu S; Bashir S; Stumm J; Kühn R
    Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.